CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Olema Pharmaceuticals, Inc. - OLMA CFD

9.02
3.56%
  • Summary
  • Historical Data
Trading сonditions
Spread 0.07
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.026179 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026179%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.003957 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003957%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 8.71
Open 8.49
1-Year Change 53.53%
Day's Range 8.49 - 9.02
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
May 24, 2024 9.02 0.29 3.32% 8.73 9.03 8.48
May 23, 2024 8.71 -0.56 -6.04% 9.27 9.27 8.58
May 22, 2024 9.17 -0.06 -0.65% 9.23 9.43 9.09
May 21, 2024 9.32 -0.01 -0.11% 9.33 9.49 9.21
May 20, 2024 9.48 -0.11 -1.15% 9.59 9.74 9.24
May 17, 2024 9.80 0.18 1.87% 9.62 9.97 9.60
May 16, 2024 9.64 -0.18 -1.83% 9.82 10.19 9.42
May 15, 2024 9.78 -0.99 -9.19% 10.77 11.06 9.58
May 14, 2024 10.14 0.86 9.27% 9.28 10.17 9.17
May 13, 2024 9.18 -0.14 -1.50% 9.32 9.73 9.13
May 10, 2024 9.28 -0.55 -5.60% 9.83 9.90 9.13
May 9, 2024 9.80 -1.24 -11.23% 11.04 11.25 9.64
May 8, 2024 10.81 0.04 0.37% 10.77 10.97 10.53
May 7, 2024 11.20 0.43 3.99% 10.77 11.25 10.50
May 6, 2024 10.85 0.19 1.78% 10.66 10.96 10.49
May 3, 2024 10.62 0.43 4.22% 10.19 10.80 10.14
May 2, 2024 10.01 -0.40 -3.84% 10.41 10.46 9.84
May 1, 2024 10.34 0.44 4.44% 9.90 10.74 9.90
Apr 30, 2024 10.10 0.23 2.33% 9.87 10.28 9.18
Apr 29, 2024 10.11 0.18 1.81% 9.93 10.29 9.93

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Olema Pharmaceuticals, Inc. Company profile

About Olema Pharmaceuticals Inc

Olema Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development, and commercialization of targeted therapies for women's cancers. Its lead product candidate, OP-1250, is an oral therapy with combined activity as both a complete estrogen receptor (ER) antagonist (CERAN) and a selective ER degrader (SERD). OP-1250 is an oral small molecule clinical-stage product candidate for the treatment of endocrine-driven cancers. It was designed based on a structural understanding of the ER. OP-1250, both as a monotherapy and in combination with inhibitors of cyclin-dependent kinase four and six (CDK4/6) demonstrated robust tumor shrinkage in several xenograft models, including a breast cancer brain metastasis model. It’s been ongoing Phase 1/2 clinical trial, and in Phase 1b combination with palbociclib, in patients with metastatic ER-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Olema Pharmaceuticals Inc revenues was not reported. Net loss applicable to common stockholders increased from $24M to $71.1M. Higher net loss reflects Research and development increase from $11.7M to $41.8M (expense), Stock-based Compensation in R&D increase from $2M to $9.3M (expense), General and administrative - Balancing increase from $6.7M to $13.8M (expense).

Industry: Biotechnology & Medical Research (NEC)

780 Brannan Street
SAN FRANCISCO
CALIFORNIA 94103
US

News

Copper price slumps as traders take profits, where to next?

Copper price drops over 5% on Thursday as traders take profits following the FOMC meeting minutes.

16:17, 24 May 2024

Market analysis: EUR/GBP driven by diverging policy expectations

The EURGBP is driven by the question: which cuts first, the ECB or the BOE? Currently, swaps markets (chart below) imply that it will be the ECB (blue line).

13:46, 24 May 2024

UK CPI Preview: Will inflation return to 2% as the BoE predicts? And how will it affect GBP?

The latest round of inflation data will be released at 22 April at 7 am BST and investors are likely going to be paying close attention.

15:44, 21 May 2024

Reserve Bank of New Zealand Preview: RBNZ could become more dovish as inflation eases and growth softens

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, May 22, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

15:29, 21 May 2024

Nvidia Q1 Earnings Preview: Analysts forecast another blockbuster set of results

Nvidia (NVDA) reports its Q1 results after the closing bell on Wednesday, May 22nd. We preview what to expect from Nvidia’s earnings and analyse its stock's technicals.

14:57, 21 May 2024
CPI, consumer price index symbol.

Disinflation resumes in the US as CPI drops in April

The rate of growth in US consumer prices dropped in April leading markets to price in more chances of rate cuts from the Fed

11:24, 16 May 2024

Stock market crash: how far can the S&P 500 go?

After a remarkably strong first quarter, the US stock market pulled back in April for the first time since October last year.

11:46, 10 May 2024

People also watch

Oil - Crude

78.58 Price
+1.100% 1D Chg, %
Long position overnight fee 0.0094%
Short position overnight fee -0.0313%
Overnight fee time 21:00 (UTC)
Spread 0.030

US100

18,829.90 Price
+0.150% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 1.8

BTC/USD

69,282.25 Price
+0.890% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

Gold

2,351.84 Price
+0.780% 1D Chg, %
Long position overnight fee -0.0195%
Short position overnight fee 0.0113%
Overnight fee time 21:00 (UTC)
Spread 0.50

Still looking for a broker you can trust?

Join the 610,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading